title: Expression of nicotinic acetylcholine receptor subunits in the cerebral cortex in Alzheimer's disease: histotopographical correlation with amyloid plaques and hyperphosphorylated-tau protein.
abstract: Impairment of cholinergic transmission and decreased numbers of nicotinic binding sites are well-known features accompanying the cognitive dysfunction seen in Alzheimer's disease (AD). In order to elucidate the underlying cause of this cholinoceptive dysfunction, the expression of two pharmacologically different nicotinic acetylcholine receptor (nAChR) subunits (alpha4, alpha7) was studied in the cerebral cortex of Alzheimer patients as compared to controls. Patch-clamp recordings of 14 dissociated neurons of control cortices showed responses suggesting the existence of alpha4- and alpha7-containing functional nAChRs in the human cortex. In cortices of Alzheimer patients and controls, the pattern of distribution and the number of alpha4 and alpha7 mRNA-expressing neurons were similar, whereas at the protein level a decrease in the density of alpha4- and alpha7-expressing neurons of approximately 30% was observed in Alzheimer patients. The histotopographical correlation of nAChR expression with accompanying pathological changes, e.g. accumulation of hyperphosphorylated-tau (HP-tau) protein and beta-amyloid showed that neurons in the vicinity of beta-amyloid plaques bore both nAChR transcripts. Neurons heavily labelled for HP-tau, however, expressed little or no alpha4 and alpha7 mRNA. These results point to an impaired synthesis of nAChRs on the protein level as a possible cause of the cholinoceptive deficit in AD. Further investigations need to elucidate whether interactions of HP-tau with nAChR mRNA, or alterations in the quality of alpha4 and alpha7 transcripts give rise to decreased protein expression at the level of individual neurons.
authors.affiliation: Department of Anatomy, University of Köln, Joseph-Stelzmann Strasse 9, 50931 Köln, Germany. wevers.anatomie@uni-koeln.de
authors.forename: A
authors.initials: A
authors.lastname: Wevers
authors.forename: L
authors.initials: L
authors.lastname: Monteggia
authors.forename: S
authors.initials: S
authors.lastname: Nowacki
authors.forename: W
authors.initials: W
authors.lastname: Bloch
authors.forename: U
authors.initials: U
authors.lastname: Schütz
authors.forename: J
authors.initials: J
authors.lastname: Lindstrom
authors.forename: E F
authors.initials: EF
authors.lastname: Pereira
authors.forename: H
authors.initials: H
authors.lastname: Eisenberg
authors.forename: E
authors.initials: E
authors.lastname: Giacobini
authors.forename: R A
authors.initials: RA
authors.lastname: de Vos
authors.forename: E N
authors.initials: EN
authors.lastname: Steur
authors.forename: A
authors.initials: A
authors.lastname: Maelicke
authors.forename: E X
authors.initials: EX
authors.lastname: Albuquerque
authors.forename: H
authors.initials: H
authors.lastname: Schröder
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000378:metabolism* / Q000473:pathology; D016229:Amyloid beta-Peptides / Q000378:metabolism; D002540:Cerebral Cortex / Q000378:metabolism*; D005260:Female; D005625:Frontal Lobe / Q000166:cytology / Q000378:metabolism; D006801:Humans; D008297:Male; D009474:Neurons / Q000378:metabolism; D010766:Phosphorylation; D058225:Plaque, Amyloid / Q000473:pathology; D020033:Protein Isoforms / Q000235:genetics / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism; D011978:Receptors, Nicotinic / Q000235:genetics / Q000378:metabolism*; D016875:tau Proteins / Q000378:metabolism
chemical_list: D016229:Amyloid beta-Peptides; D020033:Protein Isoforms; D012333:RNA, Messenger; D011978:Receptors, Nicotinic; D016875:tau Proteins